FILTER

Refine your search with the following facets to narrow down your results.

1,501 Current news from the ressort people

EUCODIS Bioscience Appoints Thomas Fischer as New CEO

08-Dec-2009 - EUCODIS Bioscience announced that it has appointed Mr Thomas Fischer, currently CFO, as new CEO of the Company. Going forward, EUCODIS Bioscience’ sole focus will be to provide high-performance enzymes to customers, capitalizing on the Company’s experience in commercial enzyme development and on ...

enzymes

Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs

07-Dec-2009 - Chiltern International Limited announced the appointment of Dr.Sharon Mooreas Executive Vice President, Global Quality & Medical Affairs. Dr. Moore is based at Chiltern's Bristol, Tennessee, USA office. Dr. Moore is a physician with 15 years of industry experience. Prior to joining Chiltern, ...

medicine pharmacovigilance quality assurance

Amsterdam Molecular Therapeutics Announces Management Changes in light of refocused strategy

04-Dec-2009 - Amsterdam Molecular Therapeutics announced a number of management changes. Piers Morgan (age 43) has been appointed Chief Financial Officer, effective December 1, 2009. Hans Preusting, PhD (age 47), Director Process Development & Manufacturing, will take up the responsibility for Operations and ...

biotechnology DSM Ernst & Young +4

Amarin appoints Joseph Zakrzewski as Executive Chairman

03-Dec-2009 - Amarin Corporation plc announced Joseph S. Zakrzewski will join the Company’s Board of Directors as Executive Chairman effective January 1, 2010. Mr. Zakrzewski has more than 20 years of industry experience, including significant contributions to Reliant Pharmaceuticals as Chief Operating ...

biotechnology chemical engineering Eli Lilly

Pergamum Appoints Jørgen Thorball as New Chairman of the Board

02-Dec-2009 - Karolinska Development AB and Pergamum AB announced the appointment of Jørgen Thorball as Chairman of the Board of Directors of Pergamum AB. Dr. Thorball has extensive experience including the successful development and commercialization of new products within the pharmaceutical and healthcare ...

Aventis business development Enzyme +2

FORMAC appoints new CEO

01-Dec-2009 - FORMAC Pharmaceuticals N.V. announced that as of January 1, 2010 Jan Rosier will become the company’s new Chief Executive Officer (CEO), replacing Laurens G. Theunis. The change in management takes place at a time where FORMAC is moving its lead program FP-0110 into Phase IIa clinical ...

hepatitis C HIV infectious diseases

Cytochroma Announces Appointment of Peter Moldt to Board of Directors

30-Nov-2009 - Cytochroma announced the appointment of Peter Moldt, PhD to its Board of Directors. Dr. Moldt will replace Mr. Ulrik Spork as the Novo A/S representative on the Company's Board. The number of Board members remains unchanged at six members. Dr. Moldt has experience in corporate strategy, company ...

drug development medicinal chemistry organic chemistry +1

Enigma Diagnostics Expands Its US and European Executive Management Teams

30-Nov-2009 - Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced four senior appointments for its US and European offices. Dr. Jorge Garces will lead the US team as President and CEO with Greg Hamilton, Chief Operating Officer and Chief Financial Officer, ...

biochemistry clinical trials cystic fibrosis +7

Dr. Simon Moroney Awarded Bavarian State Medal for Outstanding Services to the Bavarian Economy

26-Nov-2009 - MorphoSys AG announced that its co-founder and CEO Dr. Simon Moroney was awarded the Bavarian State Medal for Outstanding Services to the Bavarian Economy. The award ceremony took place at the Bavarian State Ministry of Economy, Infrastructure, Transport and Technology in Munich, Germany. "I am ...

Germany MorphoSys services

Inimex Announces Appointment of New CEO

25-Nov-2009 - Inimex Pharmaceuticals, Inc. announced that it has appointed Michael J. Abrams, Ph.D as its President and CEO. Abrams brings more than 25 years of drug discovery and development experience to Inimex. He is a co-inventor of the nuclear medicine imaging agent, Cardiolite, and worked from 1984 to ...

Bio-Medical Research Genzyme medicine +3